artemisinin has been researched along with Cardiomegaly in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, B; Dong, Y; Ma, Y; Sun, G; Xiong, Z; Zhang, C; Zhu, C | 1 |
| Gu, Y; Hu, J; Huang, C; Tang, Y; Wang, X; Wu, G; Yuan, M | 1 |
2 other study(ies) available for artemisinin and Cardiomegaly
| Article | Year |
|---|---|
Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling.
Topics: Animals; Animals, Newborn; Anti-Inflammatory Agents, Non-Steroidal; Antimalarials; Artemisinins; Cardiomegaly; Cardiotonic Agents; Cells, Cultured; Cytokines; Dose-Response Relationship, Drug; Gene Expression Regulation; Heart; I-kappa B Proteins; Male; Myocardium; Myocytes, Cardiac; NF-kappa B; NF-KappaB Inhibitor alpha; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; RNA, Small Interfering; Signal Transduction | 2010 |
Artemisinin attenuates post-infarct myocardial remodeling by down-regulating the NF-κB pathway.
Topics: Animals; Artemisinins; Blotting, Western; Cardiomegaly; Collagen Type I; Down-Regulation; Fibrosis; Hemodynamics; I-kappa B Proteins; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Infarction; Myocardium; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Rats; Rats, Sprague-Dawley; Signal Transduction; Survival Analysis; Transforming Growth Factor beta1; Ultrasonography; Ventricular Remodeling | 2012 |